| Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
Is a |
Combination ulcer healing drugs (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Clarithromycin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Metronidazole |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
Has manufactured dose form |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
Has manufactured dose form |
A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
Is a |
Product containing clarithromycin (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
Is a |
Product containing lansoprazole (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
Is a |
Product containing metronidazole (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lansoprazole (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
Is a |
Oral metronidazole |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
Has manufactured dose form |
Conventional release oral tablet (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
Has manufactured dose form |
Oral capsule |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
Is a |
Product containing lansoprazole in oral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
Is a |
Product containing clarithromycin in oral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]